Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox vs Botox with Esophageal Dilation in Achalasia
NCT03654066Phase 4Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- May 2019
- Primary completion
- Jun 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of botulinum toxin type A in achalasia (2 arms), sponsored by Vanderbilt University Medical Center. Primary endpoint: Dysphagia score at 12 months. Started May 2019; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
achalasia
Beyond the preview
Go deeper on NCT03654066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03654066.